¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024 Á¦34Â÷ ´ëÇÑÇ÷¾×ÇÐȸ ¸²ÇÁÁ¾¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¾ö : 2024-04-20

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024 Á¦34Â÷ ´ëÇÑÇ÷¾×ÇÐȸ ¸²ÇÁÁ¾¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¾ö : 2024-04-20
±³À°ÀÏÀÚ : 2024-04-20
±³À°Àå¼Ò : ·Ôµ¥¿ùµåŸ¿ö SKY31 ÄÁº¥¼Ç

±³À°ÁÖÁ¦ : 2024 Á¦34Â÷ ´ëÇÑÇ÷¾×ÇÐȸ ¸²ÇÁÁ¾¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¸²ÇÁÁ¾¿¬±¸È¸

´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581

À̸ÞÀÏ : hematology@kams.or.kr

±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú

Âü¼®¿¹»óÀÎ : 60¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 5ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í ºñȸ¿ø 50,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 20ÀÏ ROOM1 10:30~11:05 Basic Concept, Methodology and Preclinical Models of ImmunoPET ÀÌ°æÇÑ(¼º±Õ°üÀÇ´ë )

±³À°½Ã°£ 04¿ù 20ÀÏ ROOM1 11:05~11:40 Clinical Application of ImmunoPET in Cance °­¼¼·É(Àü³²ÀÇ´ë )

±³À°½Ã°£ 04¿ù 20ÀÏ ROOM1 11:40~12:30 Clinical Trials and Development Utilizing Generative A ÃÖ¼öÀÎ(°¡Å縯ÀÇ´ë )

±³À°½Ã°£ 04¿ù 20ÀÏ ROOM1 13:30~14:10 CAR-Engineered T Cell Therapy Stephen J. Schuster (University of Pennsylvania)

±³À°½Ã°£ 04¿ù 20ÀÏ ROOM1 14:10~14:50 Bispecific Antibody Therapy Georgios Spitadakis(Roche)

±³À°½Ã°£ 04¿ù 20ÀÏ ROOM1 15:10~15:45 Novel Monoclonal Antibodies and Antibody-Drug Conjugates À¯ÄèÇÑ(°¡ÃµÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ ROOM1 15:45~16:20 CAR-Engineered T Cell Therapy Àü¿ë¿ì(°¡Å縯ÀÇ´ë )

±³À°½Ã°£ 04¿ù 20ÀÏ ROOM1 16:20~16:55 Bispecific Antibody Therapy Á¤Á¾Çå(±¹¸³¾Ï¼¾ÅÍ )

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024 Á¦34Â÷ ´ëÇÑÇ÷¾×ÇÐȸ ¸²ÇÁÁ¾¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¾ö : 2024-04-20""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024³â Á¦11ȸ °­µ¿°æÈñ ºñ´¢ÀÇÇаú ½ÉÆ÷Áö¾ö : 2024-04-20
´ÙÀ½±Û Á¦4Â÷ ´ëÇѹé¹ÝÁõ»ö¼ÒÇÐȸ ½ÉÆ÷Áö¾ö : 2024-04-20
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20312 ¼­¿ï ¼¼°èÀ¯¹æ¾ÏÇмú´ëȸ 2024 ¹× Çѱ¹À¯¹æ¾ÏÇмú´ëȸ (GBCC 2024) (3ÀÏÂ÷) : 2024-04-27 0 106 2024-04-03
20311 ºÎ»ê ÇØ¿î´ë¹éº´¿ø ½Å°æ°ú ½ÉÆ÷Áö¿ò : 2024-04-27 0 143 2024-04-03
20310 ¼­¿ï Á¦29Â÷ ´ëÇÑÁÖ»êÀÇÇÐȸ Ãá°è¿¬¼ö°­Á : 2024-04-27 0 138 2024-04-03
20309 ¼­¿ï 2024³â ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ Á¦22Â÷ Á¤±âÇмú´ëȸ : 2024-04-27 0 88 2024-04-03
20308 ¼­¿ï 2024 ´ëÇÑÇ÷¾×ÇÐȸ Ç÷ÀüÁöÇ÷¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-04-27 0 126 2024-04-03
20307 °æ±â (¿Â¶óÀÎ) 2024³â Á¦1Â÷ °í·Á´ëÇб³ ¾È»êº´¿ø Á¤Çü¿Ü°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-04-27 0 132 2024-04-03
20306 ¼­¿ï 2024³â Çѱ¹½Å°æ¾È°úÇÐȸ Workshop : 2024-04-27 0 138 2024-04-03
20305 ¼­¿ï ¼¼°èÀ¯¹æ¾ÏÇмú´ëȸ 2024 ¹× Çѱ¹À¯¹æ¾ÏÇмú´ëȸ (GBCC 2024) (2ÀÏÂ÷) : 2024-04-26 0 74 2024-04-03
20304 Á¦ÁÖ 2024 ´ëÇÑÀÓ»ó¾à¸®ÇÐȸ Ãá°èÇмú´ëȸ : 2024-04-26 0 78 2024-04-03
20303 ÀüºÏ ´ëÇÑ°£ÇÐȸ ÀüºÏÁöȸ Á¦28Â÷ ¿¬¼ö±³À° : 2024-04-26 0 56 2024-04-03
20302 ¼­¿ï Á¦7ȸ º¸°ÇÀÇ·á BIG DATA ¿¬±¸ Çмú´ëȸ : 2024-04-26 0 107 2024-04-03
20301 ¼­¿ï ´ëÇÑÀÇÇÐÀ¯ÀüÇÐȸ Á¦39Â÷ Ãá°è¿¬¼ö°­Á : 2024-04-25 0 89 2024-04-03
20300 ¼­¿ï ´ëÇÑÀÇÇÐÀ¯ÀüÇÐȸ Á¦67Â÷ Ãá°èÇмú´ëȸ : 2024-04-25 0 147 2024-04-03
20299 ¼­¿ï ¼¼°èÀ¯¹æ¾ÏÇмú´ëȸ 2024 ¹× Çѱ¹À¯¹æ¾ÏÇмú´ëȸ (GBCC 2024) (1ÀÏÂ÷) : 2024-04-25 0 83 2024-04-03
20298 ¼­¿ï (¿Â¶óÀÎ) 2024³â Á¦2Â÷ û¼Ò³âÀÇÇÐ Áý´ãȸ(Áö¹æ°£Áúȯ, Çлý°Ç°­°ü¸®) : 2024-04-25 0 100 2024-04-03
61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷